GLP-1 RA vs Bariatric Surgery and Cancer Risk
Glucagon-like peptide-1 receptor agonists compared with bariatric metabolic surgery and the risk of obesity-related cancer: an observational, retrospective cohort studyWolff Sagy, Yael et al. eClinicalMedicine, Volume 83, 103213 This paper presents an observational, retrospective cohort study comparing the incidence of obesity-related cancer (ORC) in adults with obesity and diabetes treated with first-generation GLP-1 receptor agonists (GLP-1 RAs) versus bariatric metabolic surgery (BMS). […]
Ozempic and its brethren are running headlong into American dining and dieting culture
The uptick in the usage of GLP-1 drugs for weight loss, including Mounjaro, Zepbound and Ozempic, has begun careening smack into Americans’ restaurant dining habits. Restaurants were already going through it as they tried to recover from the Covid-19 pandemic. Now, that attempt to stay afloat might be all the more in danger of capsizing […]
Cigna, Novo Nordisk offer lower GLP-1 prices
The sun is setting on compounding pharmacies’ ability to make copies of hot weight loss drugs. Pharmacy benefit managers, drugmakers and telehealth companies are lowering their costs to bring patients back to brand-name treatments. …
LifeMD Launches $299 Introductory Wegovy® Bundle for Self-Pay Patients in Collaboration with Novo Nordisk
What You Should Know: – LifeMD, Inc., a provider of virtual primary care services announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy® (semaglutide). – The comprehensive package includes both the GLP-1 medication and access to LifeMD’s virtual weight management program. The initiative is part of LifeMD’s collaboration with Novo Nordisk, announced […]
Novo pressures GLP-1 compounders as FDA ban takes hold
The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off versions that have dented its sales forecasts.
New rule blocks generic versions of Ozempic and Wegovy
Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for millions. Dr. Celine Gounder joins to explain what this means for patients.
Allulose Mimics GLP-1 Hormones to Reduce Cravings and Balance Blood Sugar
Did Eli Lilly Just Say Checkmate to Novo Nordisk?
Though oncology remains the largest therapeutic area in the pharmaceutical industry, the weight management field has caught fire in the past few years. Eli Lilly (NYSE: LLY) is one of the undisputed leaders in developing anti-obesity medicines, with Novo Nordisk (NYSE: NVO) being its biggest challenger. Over the past six months, Eli Lilly has earned […]
Be Aware of Lesser-Known Downsides to GLP-1 Weight Loss
Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to the need for ongoing management of patients on GLP-1s, an obesity expert says. Medscape Medical News
THE GLP-1 BLUEPRINT, by Heidi Skolnik
Non-fiction: Health/Medicine | Nutritionist and exercise physiologist Heidi Skolnik’s THE GLP-1 BLUEPRINT